Skip to main content
RESEARCH ARCHIVE

Research Articles

Articles related to: PTSD, post-traumatic, post-traumatic stress disorder

Research Articles

Showing articles tagged with:

PTSD post-traumatic post-traumatic stress disorder
ORIGINAL RESEARCH

Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder

Bradley V. Watts, Jessica E. Hoyt, Krista D. Disano, Crystal M. Noller, Luke Rozema, Danielle M. Foster, Matthew Vincenti, Brian Shiner
Objective: Posttraumatic Stress Disorder (PTSD) is a common condition with few effective medication treatments. Glecaprevir/Pibrentasvir (GLE/PIB), a treatment for hepatitis C virus (HCV) infection, demonstrated possible evidence of effectiveness for PTSD in an epidemiological study....
Psychopharmacology Bulletin 56(1): 28-38, 2026/01/02
Pages 28-38 Read Article
ORIGINAL RESEARCH

Neuropsychological Functioning in Patients with Post Traumatic Stress Disorder Following Short Term Paroxetine Treatment

Negar Fani, Noriyuki Kitayama, Ali Ashraf, Lai Reed, Nadeem Afzal, Farhan Jawed, J. Douglas Bremner
A previous study found improvements in verbal declarative memory in patients with Posttraumatic Stress Disorder (PTSD) following one year of open-label paroxetine treatment. The purpose of the present study was to replicate prior findings and...
Psychopharmacology Bulletin 42(1): 53-68, 2025/02/03
Pages 53-68 Read Article
REVIEW ARTICLE

Stellate Ganglion Blocks for Post-Traumatic Stress Disorder: A Review of Mechanisms, Efficacy, and Complications

Jamal Hasoon, Sana Sultana, Aila Malik, Patrick Brown, Alexa Ryder, Christopher L Robinson, Ivan Urits, Giustino Varrassi, Omar Viswanath
Post-traumatic stress disorder (PTSD) stands as a pervasive psychiatric condition, exerting a profound impact on millions across the globe. Despite the availability of traditional therapeutic modalities, many individuals continue to grapple with suboptimal treatment outcomes,...
Psychopharmacology Bulletin 54(4): 106-118, 2024/08/19
Pages 106-118 Read Article
REVIEW ARTICLE

MDMA to Treat PTSD in Adults

Dustin Latimer, Michael D. Stocker, Kia Sayers, Jackson Green, Adam M. Kaye, Alaa Abd-Elsayed, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath, Ivan Urits
Post-traumatic stress disorder (PTSD) has become one of the most common psychiatric diagnosis in the United States specifically within the veteran population. The current treatment options for this debilitating diagnosis include trauma-focused psychotherapies along with...
Psychopharmacology Bulletin 51(3): 125-149, 2021/06/01
Pages 125-149 Read Article
ORIGINAL RESEARCH

Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder

Gerardo Villarreal, Mark B. Hamner, Clifford Qualls, José M. Cañive
Objectives A previous randomized placebo-controlled trial in military veterans posttraumatic stress disorder (PTSD) found that quetiapine improved global PTSD symptoms severity, depression and anxiety as well as the re-experiencing and hypearousal clusters. However, it is...
Psychopharmacology Bulletin 48(2): 8-17, 2018/02/05
Pages 8-17 Read Article
ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD
The objective of the study was to assess the efficacy and safety of aripiprazole in outpatients with posttraumatic stress disorder (PTSD) on a 12-week, open-label trial. Twenty-two subjects with DSM-IV diagnosis of PTSD participated; 16...
Psychopharmacology Bulletin 40(2): 6-18, 2007/05/07
Pages 6-18 Read Article
ORIGINAL RESEARCH

Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Post Traumatic Stress Disorder

Eric Vermetten, MD, PhD, Christian Schmahl, MD, Steven M. Southwick, MD, and J. Douglas Bremner, MD
Memory for odors is often associated with highly emotional experiences, and odors have long been noted by clinicians to be precipitants of trauma symptoms in posttraumatic stress disorder (PTSD). Primitive brain systems involved in fear...
Psychopharmacology Bulletin 40(1): 8-32, 2007/01/19
Pages 8-32 Read Article
GENERAL PSYCHOPHARMACOLOGY

Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo

Phebe Tucker, MD, Robin Potter-Kimball, RN, MS, Dorothy B. Wyatt, RN, Don E. Parker, PhD, Christie Burgin, PhD, Dan E. Jones, PhD, and Barbara K. Masters, MD
Effects of double-blind treatment of chronic posttraumatic stress disorder (PTSD) with two SSRIs and placebo on emotional symptoms and autonomic reactivity were assessed prospectively. PTSD subjects received citalopram (n=25), sertraline (n=23), or placebo (n=10) for...
Psychopharmacology Bulletin 37(3): 135-149, 2003/07/15
Pages 135-149 Read Article